Related by context. All words. (Click for frequent words.) 69 mammographic breast 67 lobular involution 65 postmenopausal hormones 65 postmenopausal hormone 65 gastric cardia 65 Heavy menstrual bleeding 65 phytoestrogen intake 64 hormone receptor negative 63 breast endometrial 63 tumor histology 62 Ovary removal 62 Cognitive impairment 62 oesophageal adenocarcinoma 62 hormone receptor status 61 hormonally sensitive 61 HER2 expression 61 impair fertility 61 fetal malformations 61 lobular breast cancer 61 FGFR2 gene 60 attain statistical significance 60 CIN3 60 invasive lobular 60 prostate cancer CaP 60 mammographic density 60 bilateral oophorectomy 60 Osteopenia 60 atypia 60 Genetic predisposition 60 atypical hyperplasia 60 Adjuvant chemotherapy 60 carotid plaque 60 Genetic variants 60 multivariable adjusted 59 liver metastasis 59 cranial irradiation 59 atypical ductal hyperplasia 59 magnesium intake 59 postmenopausal estrogen 59 subclinical hyperthyroidism 59 histologic subtype 59 multivariate adjustment 59 BRCA mutation carriers 59 invasive carcinoma 59 histological subtype 59 periprocedural MI 59 bone density measurements 59 BRCA2 carriers 59 cervical lymph node 59 colorectal adenoma 59 carotid bruit 59 Calcium intake 59 squamous cell lung cancer 59 vitamin D inadequacy 58 carotid stenosis 58 chlamydial infection 58 endometrial hyperplasia 58 hormone deprivation 58 thyroid nodules 58 lobular carcinoma 58 operable breast cancer 58 arterial calcification 58 Colorectal cancer screening 58 Chronic pancreatitis 58 obstructive coronary artery 58 carotid atherosclerosis 58 spontaneous regression 58 albumin excretion 58 CVD mortality 58 endometrial cancers 58 serum parathyroid hormone 58 fibroids endometriosis 58 clinically insignificant 58 DHEA supplementation 58 Uncontrolled hypertension 58 thromboembolisms 58 benign noncancerous 58 prostate testicular 58 neuropsychological impairment 58 PSADT 58 Overdiagnosis 58 Soy isoflavones 57 perimenopausal women 57 selenium supplementation 57 polyp recurrence 57 thyroid carcinoma 57 adjuvant systemic 57 ductal breast cancer 57 nonmelanoma 57 Colon polyps 57 Adjuvant therapy 57 LV dysfunction 57 familial clustering 57 body fatness 57 BRCA deficient 57 pancreatic lung 57 hematopoietic cancers 57 Lymph node 57 Bone density 57 breast asymmetry 57 invasive lobular carcinoma 57 endogenous estrogen 57 antioxidant supplementation 57 androgen ablation 57 prophylactic mastectomies 57 GBA mutations 57 cerebral microbleeds 57 incidentalomas 57 leiomyomas 57 MTHFD1L gene 57 HER2 positive cancers 57 Elevated PSA 57 situ LCIS 57 hormone therapy estrogen 57 postmenopausal hormone replacement 57 aortic stiffness 57 Prostate specific antigen 57 clinicopathological 57 chronic prostatitis 57 abnormal Pap smears 57 CP CPPS 57 CYP#D# inhibitor 57 arterial thickening 57 Telomere length 57 thromboembolic disease 57 perioperative morbidity 57 osteopenic 57 clinicopathologic 57 endometrial carcinoma 57 Subgroup analyzes 57 tracer uptake 56 progesterone receptor negative 56 coronary calcification 56 distal colon 56 CYP#D# genotype 56 nonfasting triglycerides 56 ASCUS 56 precursor lesions 56 residual confounding 56 carotid plaques 56 prognostic indicators 56 oophorectomy 56 fibrocystic disease 56 folate intake 56 thyrotropin levels 56 tumor subtype 56 elevated LDH 56 atherosclerotic coronary 56 advanced neoplasia 56 androgen deficiency 56 precancerous condition 56 seminomas 56 asymptomatic bacteriuria 56 Schaffir 56 postoperative mortality 56 noncancer 56 circulating estrogens 56 intact parathyroid hormone 56 nodal metastasis 56 locoregional recurrence 56 carotid IMT 56 nonhereditary 56 psychiatric comorbidity 56 ovarian hormones 56 Papillary 56 chronic prostatitis chronic 56 pCR 56 lobular carcinomas 56 testicular tumors 56 PLX STROKE targeting 56 generalisable 56 BRCA2 mutation carriers 56 ovarian uterine 56 aromatase inhibitors AIs 56 Erythropoietic therapies may 56 K ras gene 56 abdominal adiposity 56 undergo prostate biopsy 56 Chlamydia trachomatis infection 56 urothelial cancer 56 autonomic dysfunction 56 hereditary predisposition 56 Vitamin D supplementation 56 esophageal squamous cell carcinoma 56 perineural invasion 56 subclinical hypothyroidism 56 intracranial stenosis 56 limiting generalizability 56 EGFR mutation status 56 HIV HCV coinfected 56 dietary calcium intake 56 nonseminoma 56 nonfasting triglyceride levels 56 hip BMD 56 ductal carcinomas 56 antiangiogenic therapy 56 hormonally responsive 56 serum homocysteine 56 distal colon cancer 56 echocardiographic parameters 56 deCODE BreastCancer 56 poorer prognosis 56 biologic plausibility 56 Sentinel node biopsy 56 APOE genotype 56 recurrent miscarriage 56 colorectal cancer incidence 56 myocardial ischaemia 56 stratifying patients 56 colorectal adenomas 56 HER2 positive breast 56 advanced adenoma 56 genital HPV infections 56 urothelial carcinoma 56 Subclinical hypothyroidism 55 elevated CRP 55 Magnesium deficiency 55 PSA nadir 55 serum selenium 55 Hormone pills 55 precancerous tumors 55 hepatocellular carcinoma liver 55 obese postmenopausal 55 nonalcoholic steatohepatitis NASH 55 precancerous cervical 55 BRCA1 mutation carriers 55 node metastases 55 Breslow thickness 55 lymphomas leukemias 55 skeletal metastases 55 nonvertebral fracture 55 adenoma detection 55 pancreatic adenocarcinoma 55 serous ovarian cancer 55 serum lipid levels 55 carotid artery thickness 55 gastric carcinoma 55 orchitis 55 visceral adiposity 55 testicular germ cell 55 PSA kinetics 55 coinfection 55 thyroid hormone levels 55 endometrial biopsy 55 HbF 55 breast uterine 55 deCODE BreastCancer TM 55 colorectal neoplasia 55 subclinical atherosclerosis 55 Endometrial cancer 55 testosterone supplementation 55 prophylactic cranial irradiation 55 gallstone disease 55 parous women 55 nonmelanoma skin cancers 55 androgen depletion therapy 55 affective psychosis 55 postoperative AF 55 neurodevelopmental outcome 55 fragility fracture 55 chemosensitivity 55 adiponectin levels 55 CHD mortality 55 inversely associated 55 PCOD 55 nephrolithiasis 55 bacterial prostatitis 55 myomas 55 homocysteine concentrations 55 serum creatinine levels 55 Rectal cancer 55 lobular cancer 55 invasive angiography 55 extensive metabolizers 55 adnexal mass 55 progestins 55 GnRH agonists 55 heritable variation 55 Dr. Sharonne Hayes 55 Charlson comorbidity index 55 fibrocystic 55 progressive dyspnea 55 estrogen receptor negative 55 recurrent ovarian 55 breast carcinoma 55 abnormal vaginal bleeding 55 Estrogen therapy 55 Skin sterol 55 endometriosis ovarian cysts 55 SLNB 55 intestinal polyps 55 Hilakivi Clarke 55 estrogen receptor positive 55 clinicopathological features 55 gestational diabetes mellitus GDM 55 sarcomatoid 55 fatty breasts 55 venous thromboembolic disease 55 antiresorptive agents 55 osteosarcomas 55 multifactorial disease 55 subclinical disease 55 adenoma recurrence 55 pretest probability 55 Insulin sensitivity 55 Epidemiologic studies 55 serum urate levels 55 transrectal ultrasound guided 55 ovarian pancreatic 54 TMEM density 54 mammographic screening 54 ovarian malignancy 54 recurrent metastatic 54 IV bisphosphonates 54 bony metastases 54 postoperative radiotherapy 54 micro calcifications 54 polyp detection 54 selenium supplements 54 systolic dysfunction 54 waist circumference WC 54 familial pancreatic cancer 54 transferrin saturation 54 premenopausal 54 atherothrombotic disease 54 Oestrogen 54 Statin therapy 54 hydroxyvitamin D concentrations 54 serum folate concentrations 54 nonischemic cardiomyopathy 54 ICD therapy 54 spirometric 54 lymph node involvement 54 thyroid dysfunction 54 ductal cancer 54 prostate carcinoma 54 contralateral breast cancer 54 endoxifen 54 denser breasts 54 ovulatory cycles 54 Prostatitis 54 prognostic significance 54 nonmetastatic 54 atypical subtrochanteric femur fractures 54 multimodality therapy 54 diagnostic modality 54 SIADH 54 irregular menstrual cycles 54 statistically significant predictor 54 serum calcium 54 atheromatous 54 renal cysts 54 lipodystrophy syndrome 54 neurocognitive function 54 folate supplementation 54 Metastatic prostate cancer 54 Thalomid ® 54 aerodigestive tract 54 Glaxo Tykerb 54 Cardiorespiratory fitness 54 hypovitaminosis D 54 corticosteroid induced 54 loop diuretics 54 perioperative mortality 54 intima media thickness 54 Waist circumference 54 gynecologic malignancy 54 postmenopausal hormone therapy 54 tibolone 54 radiochemotherapy 54 hamartoma 54 impaired glucose metabolism 54 PNH patients 54 osteoporosis osteopenia 54 underactive thyroids 54 comorbid depression 54 intravenous bisphosphonates 54 progestin therapy 54 HER2 overexpression 54 colonoscopic 54 adjuvant therapies 54 deCODE ProstateCancer TM 54 salivary flow 54 artery calcification 54 metabolic syndrome MetS 54 perioperative complications 54 Calcium vitamin D 54 inflammatory biomarkers 54 ovarian endometrial 54 Univariate analysis 54 obstructive coronary 54 fibrate drugs 54 tumor subtypes 54 cytologic 54 curability 54 lymph node removal 54 prepregnancy BMI 54 Contraceptive pill 54 adjuvant radiotherapy 54 chromosomal alterations 54 neoplasias 54 Polycythemia vera 54 vascular dysfunction 54 medically inoperable 54 abdominal girth 54 HbA1C levels 54 dyslipidaemia 54 chronic periodontitis 54 cervix uteri 54 puerperal psychosis 54 dose Iluvien 54 estrogen deficiency 54 invasive ductal breast cancer 54 nonproliferative 54 familial predisposition 54 arterial stiffening 54 thyroid deficiency 54 helical CT 54 untreated celiac disease 54 cortisol secretion 54 Menopausal hormone therapy 54 obstructive CAD 54 recurrent venous thromboembolism 54 multivessel disease 54 dietary acrylamide 54 thrombo embolic 54 serum aminotransferase levels 54 extracolonic findings 54 serum testosterone levels 54 Hyperlipidemia 54 multi factorial disease 54 chemoprevention trials 54 triglyceride concentrations 54 undergoing hysterectomy 54 gestational hypertension 54 abnormal glucose tolerance 54 artery stenosis 54 neurocognitive deficits 54 adrenal function 54 hyperhomocysteinemia 54 precancerous colon growths 54 plasma selenium 54 familial aggregation 54 USPSTF recommends 54 preserved ejection fraction 54 non ulcer dyspepsia 54 PAP smears 54 advanced adenomas 54 metabolic derangement 54 tertiles 54 mucinous 54 AGTR1 54 aneuploidy screening 54 fructose intolerance 54 TT genotype 54 GSTT1 54 B7 H3 54 PUFA intake 54 intestinal permeability 54 fibroadenomas 54 flavonoid intake 54 baseline LDH 54 prognostic indicator 54 salivary gland tumors 53 squamous histology 53 noncardiac 53 Screening mammography 53 hypothalamic amenorrhea 53 benign prostate 53 NIHSS score 53 Her2 positive 53 colon rectal 53 transabdominal 53 dietary carbohydrate 53 thermogram 53 premalignant lesions 53 Squamous cell 53 femoral neck fracture 53 sociodemographic characteristics 53 folate supplements 53 lowest tertile 53 Androgen deprivation therapy 53 plasma triglycerides 53 BRCA gene mutation 53 HNSCC 53 precancerous polyp 53 AChE inhibitors 53 Maternal obesity 53 triglyceride concentration 53 malabsorptive 53 Radical prostatectomy 53 lymph node metastasis 53 ovarian cervical 53 CSF biomarkers 53 percutaneous biopsy 53 serum PSA 53 clinico pathological 53 morphometric vertebral fractures 53 endometrial kidney 53 MetS 53 leukocyte counts 53 plasma leptin 53 multivariate analyzes 53 HbA1C 53 liver steatosis 53 comorbid illnesses 53 myocardial infarct size 53 Socioeconomic status 53 bronchopulmonary dysplasia BPD 53 TRUS biopsy 53 mutated K ras 53 locoregional 53 nonhormonal 53 Genetic variation 53 atherothrombotic 53 underactive thyroid gland 53 pharmacologic treatments 53 anovulation 53 proximal colon 53 percutaneous cryoablation 53 catheter angiography 53 impaired insulin secretion 53 STRIDE PD 53 nondiabetic patients 53 MS relapses 53 severe periodontitis 53 minimally symptomatic 53 antiestrogen 53 insulin resistance syndrome 53 femoral neck BMD 53 pAkt 53 de novo AML 53 Aortic stenosis 53 PRESEPT study 53 microscopic colitis 53 syncope fainting 53 transfusion syndrome 53 vasomotor symptoms 53 TMPRSS2 ERG fusion 53 prostate cancer PCa 53 symptomatic fibroids 53 PCA3 scores 53 beta carotene supplementation 53 BRCA1 BRCA2 53 TGFBR1 * 6A 53 Rachel Ballard Barbash 53 Pancreatic neuroendocrine tumors 53 antireflux surgery 53 serum markers 53 cortical atrophy 53 nodal metastases 53 thyrotropin 53 colorectal tumor 53 Pneumococcal vaccination 53 DVT PE 53 preoperative chemotherapy 53 venous blood clots 53 elevated hsCRP 53 serum vitamin D 53 Ovarian cysts 53 cerebral oxygenation 53 sentinel lymph node biopsy 53 mammographic 53 serum BDNF 53 proton MR spectroscopy 53 serum uric acid 53 chorioamnionitis 53 underdiagnosis 53 Hormone therapy 53 menstrual abnormalities 53 nonalcoholic steatohepatitis 53 mammographically 53 gadolinium enhanced 53 left ventricular diastolic 53 Hip fracture 53 scintigraphic 53 unmeasured factors 53 nonpharmacologic 53 Strenuous exercise 53 systemic corticosteroid 53 leukemia multiple myeloma 53 peritoneal carcinomatosis 53 folate concentrations 53 Helicobacter pylori infection 53 abnormal pap smears 53 invasive ductal 53 Relapsing remitting MS 53 salpingo oophorectomy 53 overexpress HER2 53 vestibular schwannomas 53 suicide ideation 53 amyloid plaque formation 53 mineral density 53 electron beam computed tomography 53 carbohydrate intolerance 53 potassium excretion 53 underlying pathophysiology 53 nondiabetics 53 postoperative atrial fibrillation 53 breast ovary 53 N telopeptide 53 Boston DbTechNo Results 53 epithelial ovarian cancer 53 endocrine therapies 53 uterine tumors 53 subfertility 53 multivariable analysis 53 colorectal cancer CRC 53 comorbid disorders 53 Carotid endarterectomy 53 thigh circumference 53 VLDL cholesterol 53 gene amplification 53 Hb A1C 53 Chronic Lyme disease 53 axillary lymph nodes 53 PHPT 53 LNG IUS 53 Calcium supplementation 53 AST ALT 53 serum GGT 53 dexrazoxane 53 VEGF expression 53 capsular contracture 53 BRCA2 mutations 53 taxane therapy 53 hormone therapy HT 53 plasma homocysteine 53 VLBW infants 53 gross hematuria 53 serum calcium levels 53 abnormal glucose metabolism 53 cardiac repolarization 53 serum estradiol 53 male hormones androgens 53 isolated systolic hypertension 53 micronutrient intake 53 differentiated thyroid 53 ICD implantation 53 pelvic malignancies 53 dyssynchrony 53 periodontal infection 53 Pap smear screening 53 hydroxyvitamin D levels 53 nonpregnant women 53 colorectal neoplasms 53 depressive symptomatology 53 premenopausal breast cancer 53 BRCA carriers 53 hypercoagulable 53 Hemolytic uremic syndrome 53 genital ulcer 52 untreated OSA 52 penetrance 52 psychiatric comorbidities 52 osteoporotic vertebral compression fractures 52 circulating endothelial cells 52 metaplasia 52 cardiovascular disease hypertension 52 urodynamic parameters 52 RBP4 levels 52 premenopausal women 52 preoperative PSA 52 antioxidant intake 52 Enlarged prostate 52 ductal lobular 52 elevated TSH 52 prognostically 52 fatal IHD 52 predisposing factor 52 overt hypothyroidism 52 microsatellite instability 52 artery elasticity 52 BRCA mutation 52 fragility fractures 52 Subclinical 52 cardio respiratory fitness 52 bone scintigraphy 52 CIN2 + 52 Suicidal ideation 52 Randomized trials 52 noncardiovascular mortality 52 OSAHS 52 KRAS mutation 52 thiopurine 52 thiazide diuretics 52 malignant neoplasm 52 lifetime abstainers 52 antiplatelet medications 52 prophylactic oophorectomy 52 Coronary artery calcium 52 faulty BRCA genes 52 pancreatic prostate 52 progesterone receptor PR 52 serum PTH 52 colorectal gastric 52 lumbar disk herniation 52 gonococcal infection 52 KIF6 carriers 52 adenomatous 52 cryptogenic 52 lumbar spine BMD 52 prostate abnormalities 52 interindividual variability 52 sonographically guided 52 postoperative complication 52 thyroid stimulating hormone 52 hormonal stimulation 52 NSTEMI 52 molar pregnancy 52 Sleep disturbances 52 serum triglycerides 52 hippocampal volume 52 antenatal depression 52 coronary microvascular 52 BRCA mutations 52 nonmelanoma skin cancer 52 cisplatin resistant 52 Premature menopause 52 FeNO 52 Avandia Actos 52 oocytes retrieved 52 urinary calcium 52 medication nonadherence 52 APOE ε4 52 prostate bladder 52 endometrial thickness 52 PSA velocity 52 borderline statistical significance 52 irregular menses 52 ejection fractions 52 hydroxy vitamin D 52 neurodevelopmental impairment 52 core needle biopsies 52 comorbid psychiatric 52 Calorie intake 52 axillary node 52 elevated homocysteine 52 plasma homocysteine levels 52 Hormonal therapy 52 BMD measurements 52 endometrial cancer 52 inhibit ovulation 52 esophageal adenocarcinoma 52 postoperative morbidity 52 ratio WHR 52 amenorrhoea 52 newer atypical antipsychotics 52 SCr 52 Kattlove 52 unmeasured confounding 52 placental malaria 52 CLA supplementation 52 Abbott Trilipix 52 Symptom severity 52 Mild hypothermia 52 Breast Density 52 urolithiasis 52 antidiabetic medication 52 Hurthle cell 52 endometrial lining 52 metabolic disturbances 52 axillary dissection 52 psychosocial variables 52 conventional coronary angiography 52 trans palmitoleate 52 Endothelial function 52 BRCA testing 52 Fatty liver 52 premenopause 52 postmenopause 52 Histologic 52 specific antigen PSA 52 endocrinologic 52 EUS FNA 52 albumin excretion rate 52 pre menopausal 52 FDG PET imaging 52 lipid lowering therapy 52 retrospective observational 52 CYP#D# gene 52 Femara letrozole 52 alendronate Fosamax 52 KRAS status 52 mCRPC 52 estrogen metabolism 52 hypertension diabetes mellitus 52 irregular menstrual periods 52 Febrile neutropenia 52 hemodilution 52 dose ionizing radiation 52 Multivariate analyzes 52 lichen planus 52 thicker carotid arteries 52 abnormal lipid levels 52 estrogen metabolites 52 probiotic supplementation 52 oropharyngeal cancer 52 extrapyramidal symptoms 52 noncardiovascular 52 laryngeal cancers 52 ACOG guidelines 52 IPAH 52 primary spontaneous pneumothorax 52 silent myocardial ischemia 52 uncircumcised males 52 postoperative pulmonary 52 Folate deficiency 52 DEXA scan 52 generalizability 52 perinatal mortality 52 tamoxifen raloxifene 52 hMG 52 myocardial viability 52 atherosclerotic vascular disease 52 platelet reactivity 52 metabolic dysregulation 52 perinatal outcomes 52 diabetes mellitus DM 52 LV hypertrophy 52 conditional logistic regression 52 naturally occurring estrogen 52 isoflavone supplements 52 breast cancer recurrence 52 #.#ng/ml 52 Endometrial 52 renal carcinoma 52 Metastases 52 differential gene expression 52 Pelvic Inflammatory Disease 52 antiandrogens 52 abnormal cytology 52 refractive correction 52 immune reconstitution syndrome 52 unmeasured confounders 52 EGFR expression 52 dietary glycemic index 52 epithelial tumors 52 thiazide 52 chemopreventive agent 52 glomerular filtration 52 inflammatory rheumatic 52 serum cotinine levels 52 angiographically 52 p#INK#a 52 monogenic 52 H. pylori infections 52 haematologic 52 allogeneic HSCT 52 thrombotic complications 52 mean ± SEM 52 cutaneous malignant melanoma 52 beta adrenergic receptor 52 intracerebral haemorrhage 52 Postmenopausal hormone therapy 52 #OHD levels 52 benign breast 52 C1 INH deficiency 52 Bacterial vaginosis 52 mechanistic studies 52 prescribe statins 52 endometrial 52 biochemical recurrence 52 Stress urinary incontinence 52 extracapsular extension 52 aldosterone hormone 52 sociodemographic factors 52 Combination antiretroviral therapy 52 rates Tangka 52 contralateral breast 52 pretransplant 52 Epidemiological studies 52 growth hormone secretion 52 androgen deprivation 52 shorter telomere length 52 troponin T 52 baseline mammogram 52 SCK difficulty 52 mammograms Mikulski 52 prognostic variables 52 spontaneous preterm delivery 52 taxane refractory 52 bladder cancers 52 oncologic outcomes 52 precancer 52 osteoporotic bone 52 chronicity 52 prolongs survival 52 authors hypothesize 52 Adequate vitamin D 52 dysfunctional voiding 52 carotid artery blockage 52 urinary cortisol 52 gastrointestinal GI bleeding 52 vascular reactivity 52 potent inducer 52 KRAS oncogene 52 cardio metabolic 52 distant metastases 51 RET PTC rearrangements 51 micrometastases 51 glial tumors 51 serum thyroglobulin 51 Uterine cancer 51 undergo radical prostatectomy 51 Postmenopausal 51 menopausal hormone therapy 51 Tibolone 51 cervical carcinoma 51 abnormal mammograms 51 serum phosphate levels 51 pulmonary dysfunction 51 follicular adenoma 51 Osteoporotic fractures 51 TOP2A 51 pelvic girdle pain 51 cellularity 51 Dr Zorbas 51 neoadjuvant radiation 51 adenomatous polyp 51 Tasigna prolongs 51 Comorbidities 51 ovary uterus 51 BRCA1 mutations 51 comorbid anxiety 51 2D 4D length 51 LRP5 51 coexisting illnesses 51 haemorrhagic stroke 51 antioxidant vitamin supplements 51 conjugated estrogen 51 socioeconomic variables 51 Progestin 51 potentially modifiable 51 hormonal abnormalities 51 detecting precancerous 51 VLBW 51 baseline HbA1c 51 abnormal lipids 51 cardiac dysfunction 51 narcolepsy cataplexy 51 apneic episodes 51 Oesophageal cancer 51 prospectively stratified 51 microscopic lesions 51 Vitamin D deficient 51 Lowering cholesterol 51 coronary revascularizations 51 overt hepatic encephalopathy HE 51 beta blocker therapy 51 Memory Study WHIMS 51 chromium supplementation 51 estimated GFR 51 breast tenderness 51 preventive mastectomy 51 metachronous 51 microbleeds 51 transient elastography 51 lactate dehydrogenase LDH 51 hypercalcaemia 51 p# mutations 51 deep venous thromboses 51 estrogen hormone therapy 51 cervical prostate 51 hepatic fat 51 Renal dysfunction 51 Prostate enlargement 51 GSTM1 51 axial length 51 Basal Cell 51 metastatic basal cell 51 surgical biopsy 51 varicoceles 51 serum sodium levels 51 Endothelial dysfunction 51 acetabular fractures 51 pathologic fractures 51 Logistic regression analysis 51 Ductal carcinoma 51 polycystic ovarian disease 51 bone density scans 51 β blockers 51 telomere lengths 51 primary ovarian insufficiency 51 serum phosphate 51 Brain metastases 51 BMI percentiles 51 proliferative retinopathy 51 CT angiography CTA 51 serum lipid 51 FDG-PET/CT 51 tamoxifen Nolvadex ® 51 diffuse gastric 51 T2 lesions 51 cutaneous melanoma 51 Vigorous exercise 51 fatty infiltration 51 recurrent VTE 51 Heritability